跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
维福瑞 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Sucroferric Oxyhydroxide Chewable Tablets
Approved
化学药品
Sucroferric Oxyhydroxide Chewable Tablets
Vifor Fresenius Medical Care Renal Pharma Ltd.
🇨🇳 National Medical Products Administration
Approval Date
Feb 21, 2023
Approval ID
1d05749f45323f79
Company
Vifor Fresenius Medical Care Renal Pharma Ltd.
Type
化学药品
Approval Details
Approval Id
1d05749f45323f79
Approval Number
国药准字HJ20233131
Generic Name
蔗糖羟基氧化铁咀嚼片
Generic Name En
Sucroferric Oxyhydroxide Chewable Tablets
Trade Name
维福瑞
Drug Type
化学药品
Dosage Form
片剂
Strength
0.5g(按Fe计)
Reg Date
2023-02-21
Expired Date
2028-02-20
Company Name
Vifor Fresenius Medical Care Renal Pharma Ltd.
Production Company Name
Corden Pharma Fribourg SA
Company Detail Path
/organization/vifor-fresenius-medical-care-renal-pharma-ltd
Production Company Detail Path
/organization/corden-pharma-fribourg-sa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 21, 2023
Approval ID
1d05749f45323f79
Type
化学药品
Back to NMPA Approvals